Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ethylenediamine Dihydrochloride Vehicle Formulations
NCT01798589Phase 4Completed
- Sponsor
- Allerderm Laboratories, Inc.
- Start
- Jul 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ethylenediamine dihydrochloride in allergic contact dermatitis (ACD), sponsored by Allerderm Laboratories, Inc.. Started Jul 2012; status: completed.
02
Drugs
ethylenediamine dihydrochloride
03
Conditions
allergic contact dermatitis (ACD)
Beyond the preview
Go deeper on NCT01798589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798589.